Suppr超能文献

低浓度静脉注射聚明胶肽会促进低分子量蛋白尿。

Low concentrations of intravenous polygelines promote low-molecular weight proteinuria.

作者信息

Veldman B A J, Schepkens H L E, Vervoort G, Klasen I, Wetzels J F M

机构信息

Department of Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands.

出版信息

Eur J Clin Invest. 2003 Nov;33(11):962-8. doi: 10.1046/j.1365-2362.2003.01258.x.

Abstract

BACKGROUND

Previously we observed that atrial natriuretic peptide (ANP)-induced albuminuria was accompanied by an increase in urinary excretion of the low-molecular weight protein (LMW protein) beta2-microglobulin (beta2-m), suggesting that the albuminuria may at least partly be the result of blockade of tubular protein reabsorption. However, in our experiments ANP was dissolved in the polygeline Haemaccel (Hoechst, Behring-Werke, Marburg Germany) to prevent adhesion of ANP to the infusion system. Anecdotal reports have shown that high dosages of polygelines such as Haemaccel or Gelofusine (Braun NPBI Oss, the Netherlands) may influence tubular protein handling. In the present study we have evaluated the effect of a low and high doses of the polygeline Haemaccel on proteinuria. In addition, we have reassessed the effects of ANP.

MATERIALS AND METHODS

We measured urinary beta2-microglobulin (beta2-m) and albumin excretion in healthy volunteers after infusion of a high-dose pure Haemaccel (0.04 mL kg(-1) min(-1) for 60 min), a low-dose Haemaccel (0.01 mL kg(-1) min(-1) for 60 min followed by infusion of 0.02 mL kg(-1) min(-1) for 60 min) and a low-dose Gelofusine (dose comparable to the low-dose Haemaccel). In addition we performed similar studies using ANP dissolved in saline and Haemaccel.

RESULTS

Infusion of Haemaccel caused a dose-dependent increase in urinary excretion of beta2-m. There were no differences between Haemaccel and Gelofusine. After infusion of ANP dissolved in Haemaccel urinary beta2-m excretion increased from 0.05 +/- 0.03 microg min(-1) to 27 +/- 10 microg min(-1) and urinary albumin excretion increased from 4.5 +/- 1.1 microg min(-1) to 9.7 +/- 6.3 microg min(-1) (P<0.05). During ANP + saline infusion, urinary beta2-m excretion did not change, whereas the urinary albumin excretion increased from 5.3 +/- 1.5 microg min(-1) to 7.9 +/- 2.4 microg min(-1) (P<0.05).

CONCLUSIONS

Our study demonstrates that even low doses of the polygelines Haemaccel and Gelofusine profoundly attenuate the tubular reabsorption of the low-molecular weight protein beta2-m. Atrial natriuretic peptide does not affect tubular protein reabsorption. Therefore, the rise in albuminuria during ANP infusion most likely reflects alterations in glomerular permeability.

摘要

背景

此前我们观察到,心房利钠肽(ANP)诱导的蛋白尿伴随着低分子量蛋白(LMW蛋白)β2-微球蛋白(β2-m)尿排泄增加,提示蛋白尿可能至少部分是肾小管蛋白重吸收受阻的结果。然而,在我们的实验中,ANP溶解于聚明胶肽贺斯(德国马尔堡赫斯特贝林werke公司)中,以防止ANP黏附于输注系统。有报道称,高剂量的聚明胶肽如贺斯或佳乐施(荷兰布劳恩NPBI奥斯公司)可能影响肾小管对蛋白的处理。在本研究中,我们评估了低剂量和高剂量的聚明胶肽贺斯对蛋白尿的影响。此外,我们重新评估了ANP的作用。

材料与方法

我们在健康志愿者中测量了输注高剂量纯贺斯(按0.04 mL·kg-1·min-1输注60分钟)、低剂量贺斯(先按0.01 mL·kg-1·min-1输注60分钟,随后按0.02 mL·kg-1·min-1输注60分钟)和低剂量佳乐施(剂量与低剂量贺斯相当)后尿β2-微球蛋白(β2-m)和白蛋白排泄情况。此外,我们使用溶解于生理盐水和贺斯中的ANP进行了类似研究。

结果

输注贺斯导致尿β2-m排泄呈剂量依赖性增加。贺斯与佳乐施之间无差异。输注溶解于贺斯中的ANP后,尿β2-m排泄从0.05±0.03μg·min-1增加至27±10μg·min-1,尿白蛋白排泄从4.5±1.1μg·min-1增加至9.7±6.3μg·min-1(P<0.05)。在输注ANP+生理盐水期间,尿β2-m排泄未改变,而尿白蛋白排泄从5.3±1.5μg·min-1增加至7.9±2.4μg·min-1(P<0.05)。

结论

我们的研究表明,即使是低剂量的聚明胶肽贺斯和佳乐施也会显著减弱肾小管对低分子量蛋白β2-m的重吸收。心房利钠肽不影响肾小管蛋白重吸收。因此,输注ANP期间蛋白尿增加很可能反映了肾小球通透性的改变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验